These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24292574)

  • 1. B-scan ultrasonographic monitoring of orthotopic xenografted plexiform neurofibroma in mice.
    Gleiss J; Demestre M; Spyra M; Eschenhagen T; Hagel C; Mautner VF; Kluwe L; Friedrich RE
    In Vivo; 2013; 27(6):723-7. PubMed ID: 24292574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imatinib mesylate (Glivec) inhibits Schwann cell viability and reduces the size of human plexiform neurofibroma in a xenograft model.
    Demestre M; Herzberg J; Holtkamp N; Hagel C; Reuss D; Friedrich RE; Kluwe L; Von Deimling A; Mautner VF; Kurtz A
    J Neurooncol; 2010 May; 98(1):11-9. PubMed ID: 19921098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nilotinib is more potent than imatinib for treating plexiform neurofibroma in vitro and in vivo.
    Wei J; Freytag M; Schober Y; Nockher WA; Mautner VF; Friedrich RE; Manley PW; Kluwe L; Kurtz A
    PLoS One; 2014; 9(10):e107760. PubMed ID: 25340526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental therapy for neurofibromatosis I shows promise: cancer drug shrinks some plexiform neuromas.
    Am J Med Genet A; 2013 Feb; 161A(2):viii-ix. PubMed ID: 23348988
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of nerve microenvironment for neurofibroma development.
    Liao CP; Pradhan S; Chen Z; Patel AJ; Booker RC; Le LQ
    Oncotarget; 2016 Sep; 7(38):61500-61508. PubMed ID: 27517146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant transformation in a sciatic plexiform neurofibroma in Neurofibromatosis Type 1 - imaging features that aid diagnosis.
    Chew DCY; Zhao DBH; Sittampalam K; Kumar SK
    J Radiol Case Rep; 2020 Dec; 14(12):1-13. PubMed ID: 33717399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial.
    Robertson KA; Nalepa G; Yang FC; Bowers DC; Ho CY; Hutchins GD; Croop JM; Vik TA; Denne SC; Parada LF; Hingtgen CM; Walsh LE; Yu M; Pradhan KR; Edwards-Brown MK; Cohen MD; Fletcher JW; Travers JB; Staser KW; Lee MW; Sherman MR; Davis CJ; Miller LC; Ingram DA; Clapp DW
    Lancet Oncol; 2012 Dec; 13(12):1218-24. PubMed ID: 23099009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal study of neurofibromatosis 1 associated plexiform neurofibromas.
    Tucker T; Friedman JM; Friedrich RE; Wenzel R; Fünsterer C; Mautner VF
    J Med Genet; 2009 Feb; 46(2):81-5. PubMed ID: 18930997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early administration of imatinib mesylate reduces plexiform neurofibroma tumor burden with durable results after drug discontinuation in a mouse model of neurofibromatosis type 1.
    Armstrong AE; Rhodes SD; Smith A; Chen S; Bessler W; Ferguson MJ; Jiang L; Li X; Yuan J; Yang X; Yang FC; Robertson KA; Ingram DA; Blakeley JO; Clapp DW
    Pediatr Blood Cancer; 2020 Aug; 67(8):e28372. PubMed ID: 32459399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rare manifestation of Neurofibromatosis type 1: A plexiform neurofibroma involving the mediastinum and lungs with endobronchial neurofibromata.
    Pascoe HM; Antippa P; Irving L; Christie M; McCusker MW
    J Med Imaging Radiat Oncol; 2019 Feb; 63(1):76-78. PubMed ID: 30238622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of plexiform neurofibroma: tumor-stromal/hematopoietic interactions in tumor progression.
    Staser K; Yang FC; Clapp DW
    Annu Rev Pathol; 2012; 7():469-95. PubMed ID: 22077553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiological manifestations of abdominopelvic nerve tumours seen in neurofibromatosis type 1.
    Ozcan HN; Karcaaltincaba M; Oguz B; Haliloglu M
    Clin Radiol; 2014 Apr; 69(4):431-5. PubMed ID: 24361143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-parotid facial nerve multiple plexiform neurofibroma in patient with NF1.
    Fadda MT; Verdino G; Mustazza MC; Bartoli D; Iannetti G
    Int J Pediatr Otorhinolaryngol; 2008 May; 72(5):553-7. PubMed ID: 18329107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical plexiform neurofibroma in NF1 with high standardised uptake value (SUV) in positron-emission tomography (PET) expressing podoplanin.
    Friedrich RE; Derlin T; Hagel C
    In Vivo; 2010; 24(6):871-6. PubMed ID: 21164047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marrow signal changes observed in follow-up whole-body MRI studies in children and young adults with neurofibromatosis type 1 treated with imatinib mesylate (Gleevec) for plexiform neurofibromas.
    Karmazyn B; Cohen MD; Jennings SG; Robertson KA
    Pediatr Radiol; 2012 Oct; 42(10):1218-22. PubMed ID: 22722872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revisiting the NPcis mouse model: A new tool to model plexiform neurofibroma.
    Plante C; Mohamad T; Hewa Bostanthirige D; Renaud M; Sidhu H; ElChoueiry M; Vatasescu JS; Poirier M; Geha S; Brosseau JP
    PLoS One; 2024; 19(6):e0301040. PubMed ID: 38900740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment for plexiform neurofibromas in patients with NF1.
    Ardern-Holmes SL; North KN
    Lancet Oncol; 2012 Dec; 13(12):1175-6. PubMed ID: 23099008
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinic-based study of plexiform neurofibromas in neurofibromatosis 1.
    Waggoner DJ; Towbin J; Gottesman G; Gutmann DH
    Am J Med Genet; 2000 May; 92(2):132-5. PubMed ID: 10797438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Plexiform neurofibroma in the gingiva].
    Savaş H; Karabacakoğlu A; Karaköse S; Durmuş E
    Tani Girisim Radyol; 2004 Mar; 10(1):39-43. PubMed ID: 15054702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rare case of plexiform neurofibroma of the liver in a patient without neurofibromatosis type 1.
    Nebiki H; Hiramatsu S; Sakata Y; Suekane T; Yamasaki T; Nakai T; Koda Y; Kanazawa A; Inoue T
    Clin J Gastroenterol; 2020 Dec; 13(6):1297-1302. PubMed ID: 32918724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.